Boston University Department of Pharmacology and Experimental Therapeutics
Presents
Wyeth Symposium on Metabolic Dysregulation
Wednesday, October 22, 2008, 8:30 a.m. – 5:00 p.m.
Trustees Ballroom, 1 Sherborn Street, 9th Floor, Boston, MA 02215
Free and Open to the Public. Continental Breakfast at 8:15 a.m.
For More Information and/or to Register, Please contact: pharm3@bu.edu
Steven A. Kliewer, Ph.D.
University of Texas Southwestern Medical Center
The Role of Nuclear Receptors in Carbohydrate and Lipid Metabolism
Gary E. Landreth, Ph.D.
Case Western Reserve University
Inflammations, PPARs and Neurodegenerative Disease
Timothy F. Osborne, Ph.D.
University of California, Irvine
Transcriptional Regulation of Lipid Metabolism & Nutrient Sensing in Diabetes, Obesity & Atherosclerosis
Giulio M. Pasinetti, M.D., Ph.D.
Mount Sinai School of Medicine
Inflammation and Alzheimer’s Disease: Are We Well ADAPTed?
Pere Puigserver, Ph.D.
Dana Farber Cancer Institute
Biological Responses to Hormonal and Nutrient Signals that Control Metabolism
David R. Riddell, Ph.D.
Wyeth Research Neuroscience Discovery
The LXR Agonist TO901317 Selectively Lowers Hippocampal ABeta42 and Improves Memory in the Tg2576 Mouse Model of Alzheimer’s Disease
Sudha Seshadri, M.D.
Boston University School of Medicine
Inflammatory Markers and the Risk of Alzheimer’s Disease: the Framingham Study
